ZBIO compared with MBX: revenue, margins and what each company keeps, and the suppliers and customers both name

ZBIOZenas BioPharma, Inc.

Mkt capRevenueRevenue

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ZBIOZenas BioPharma, Inc.

MBXMBX Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ZBIO

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−6.68%—

May 13 '26±6.7%▲+4.02%×0.60

Q1 FY26±14.6%▼−3.37%×0.23

Jan 5 '26±33.7%▼−51.86%×1.54

MBX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−0.55%—

May 7 '26±11.9%▲+8.06%×0.68

= impliedZBIO realized, solidMBX realized, hatchedOne scale, both sides: full bar = 52%× = |realized| ÷ impliedSource: market data

Q1 FY26

±16.9%

▼−3.42%

×0.20

Jan 12 '26±17.0%▲+15.19%×0.89

ZBIOZenas BioPharma, Inc.

28.37▲+2.71%· post 28.37· delayed

Mkt cap$1.7BRevenue$1MQ2 FY26

MBXMBX Biosciences, Inc.

55.05▲+1.20%· post 55.05· delayed

After hoursNov 3 '26delayed

Mkt cap$2.6BRevenue—

Compare

After hoursNov 3 '26delayed

ZBIOZenas BioPharma, Inc.

MBXMBX Biosciences, Inc.

28.37▲+2.71%post 28.37delayed

Price

55.05▲+1.20%post 55.05delayed

$1.7B

Mkt cap

$2.6B

Q2 FY26$1M

Revenue

—

ZBIO28.37▲+2.71%vsMBX55.05▲+1.20%After hoursNov 3 '26delayed